青少年分化型甲状腺癌与<sup>131</sup>I治疗

陈永辉

青少年分化型甲状腺癌与¹³¹I治疗

陈永辉

文章导航 > 国际放射医学核医学杂志 > 2008, 32 > 6: (354-356)

引用本文:

Citation:

青少年分化型甲状腺癌与¹³¹I治疗

陈永辉

100730 北京, 中国医学科学院北京协和医院核医学科

Radioactive iodine treatment of differentiated thyroid carcinoma in teenager

CHEN Yong-hui

Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

摘要: 青少年分化型甲状腺癌发病率不高,但与成人分化型甲状腺癌相比,具有一些鲜明的特征:发现时往往体积较大,诊断时多出现颈部淋巴结或远处转移,肿瘤细胞钠。碘转运体表达数量和频率多,治疗后复发率高,尽管如此,其总体存活率较高。手术后¹³¹I去除残余甲状腺组织和¹³¹I治疗远处转移依然是治疗青少年分化型甲状腺癌的重要手段。
- 碘放射性同位素 /
- 甲状腺肿瘤 /
- 近距离放射疗法 /
- 青少年
Abstract: Incidence rate of differentiated thyroid carcinoma in teenager is not high. It has some different characteristics compared to adult differentiated thyroid carcinoma. Such as larger tumor at diagnosis; greater prevalence of neck lymph node and distant metastases at diagnosis; more sodium-iodide symporter expression; high recurrence rate but higher overall survival rate. ¹³¹I administration to remove residual thyroid tissue and treat metastases is still one of the important approaches after surgery.

本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Mazzaferri EL,Kloos RT. Clinical review 128:Current approaches to primary therapy for papillary and follicular thyroid cancer[J]. J Clin Endocrinol Metab,2001,86(4):1447-1463.
[2]	Zimmerman D,Hay ID,Gough IR,et al. Papillary thyroid carcinoma in children and adults:long-term follow-up of 1039 patients conservatively treated at one institution during three decades[J]. Surgery,1988,104(6):1157-1166.
[3]	Farahati J,Bucsky P,Parlowsky T,et al. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age,gender,and history[J]. Cancer,1997,80(11):2156-2162.
[4]	Ringel MD,Anderson J,Souza SL,et al. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer[J]. Mod Pathol,2001,14(4):289-296.
[5]	Patel A,Jhang S,Dogra S,et al. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents[J]. Pediatr Res,2002,52(5):737-744.
[6]	Khan MU,Nawaz MK,Saadullah M,et al. Differentiated thyroid carcinoma in a juvenile patient[J]. Clin Nucl Med,2008,33(5):319-320.
[7]	Parisi MT,Mankoff D,Differentiated pediatric thyroid cancer,correlates with adult disease,controversies in treatment[J]. Semin Nucl Med,2008,37(5):340-356.
[8]	Sisson JC,Giordano TJ,Jamadar DA,et al. 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma[J]. Cancer,1996,78(10):2184-2192.
[9]	Hung W,Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid Cancer:a review[J]. Thyroid,2002,12(8):683-702.
[10]	Dottorini ME,Vignati A,Mazzucchelli L,et al. Differentiated thyroid carcinoma in children and adolescents:a 37-year experience in 85 patients[J]. J Nucl Med,1997,38(5):669-675.
[11]	Samuel AM,Rajashekharrao B,Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer[J]. J Nucl Med,1998,39(9):1531-1536.
[12]	Junak DH,Wloch J,Roskosz J,et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregion-al recurrence risk in childhood and adolescent differentiated thyroid cancer[J]. J Nucl Med,2007,48(6):879-888.
[13]	Bal CS,Kumar A,Pant GS. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma:a randomized clinical trial in 509 patients[J]. J Clin Endocrinol Metab,2004,89(4):1666-1673.
[14]	Dinauera CA,Breuerb C,Rivkees SA. Differentiated thyroid cancer in children; diagnosis and management[J].Curr Opin Oncol,2008,20(1):59-65.

[1]	冯菲 , 赵德善 . ¹³¹I治疗青少年儿童甲状腺功能亢进症. 国际放射医学核医学杂志, 2009, 33(3): 171-174,183. doi: 10.3760/cma.j.issn.1673-4114.2009.03.011
[2]	牟联超 , 李先映 , 石彩虹 . ¹³¹Ⅰ治疗青少年Graves病58例临床分析. 国际放射医学核医学杂志, 2010, 34(5): 299-301. doi: 10.3760/cma.j.issn.1673-4114.2010.05.013
[3]	李佳 , 秦岚 , 任众 , 张又萍 . ¹³¹I治疗青少年Graves病的量效分析. 国际放射医学核医学杂志, 2010, 34(3): 152-155. doi: 10.3760/cma.j.issn.1673-4114.2010.03.006
[4]	郑艳 , 赵德善 , 付松海 , 冯菲 , 耿会霞 , 孙琦婷 , 陆克义 , 李保军 , 李思进 . 儿童和青少年Graves甲亢患者¹³¹I治疗剂量的分析研究. 国际放射医学核医学杂志, 2013, 37(2): 69-73. doi: 10.3760/cma.j.issn.1673-4114.2013.02.002
[5]	杨凡慧 , 陈跃 , 张春银 . ¹³¹I治疗青少年及儿童格雷夫斯甲亢的临床应用随访研究. 国际放射医学核医学杂志, 2017, 41(2): 98-102. doi: 10.3760/cma.j.issn.1673-4114.2017.02.004
[6]	陈志军 , 谭丽玲 , 王文俊 , 周爱清 . ¹³¹I联合¹²⁵I粒子治疗难治性甲状腺癌骨转移一例. 国际放射医学核医学杂志, 2017, 41(1): 76-78. doi: 10.3760/cma.j.issn.1673-4114.2017.01.015
[7]	李艳玲 , 栾兆生 . 维甲酸在¹³¹I治疗分化型甲状腺癌中的应用. 国际放射医学核医学杂志, 2009, 33(4): 226-228. doi: 10.3760/cma.j.issn.1673-4114.2009.04.010
[8]	董峰 , 周荫保 . 分化型甲状腺癌术后¹³¹I清甲效果的影响因素. 国际放射医学核医学杂志, 2010, 34(1): 27-31. doi: 10.3760/cma.j.issn.1673-4114.2010.01.007
[9]	张璐 , 詹维伟 , 张一帆 . 颈部超声在分化型甲状腺癌¹³¹I治疗中的应用进展. 国际放射医学核医学杂志, 2014, 38(4): 271-274. doi: 10.3760/cma.j.issn.1673-4114.2014.04.015
[10]	易婉婉 , 袁雪宇 , 蔡海东 , 刘瑾 , 张倩 , 范素云 , 吕中伟 . ¹³¹I治疗分化型甲状腺癌术后患者辐射剂量预测模型的研究. 国际放射医学核医学杂志, 2022, 46(2): 67-72. doi: 10.3760/cma.j.cn121381-202102004-00139

点击查看大图

计量

文章访问数: 1559
HTML全文浏览量: 163
PDF下载量: 2

青少年分化型甲状腺癌与¹³¹I治疗

陈永辉

100730 北京, 中国医学科学院北京协和医院核医学科

收稿日期: 2008-06-21

关键词:

摘要: 青少年分化型甲状腺癌发病率不高,但与成人分化型甲状腺癌相比,具有一些鲜明的特征:发现时往往体积较大,诊断时多出现颈部淋巴结或远处转移,肿瘤细胞钠。碘转运体表达数量和频率多,治疗后复发率高,尽管如此,其总体存活率较高。手术后¹³¹I去除残余甲状腺组织和¹³¹I治疗远处转移依然是治疗青少年分化型甲状腺癌的重要手段。